Clinical Trials on Limb Girdle Muscular Dystrophy R9 FKRP-related in Netherlands

Total 5 results

ML Bio Solutions, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) (Fortify)

Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

United States, Netherlands, United Kingdom, Denmark, Australia, Italy, Norway
Virginia Commonwealth University
University of Colorado, Denver; Washington University School of Medicine; University... and other collaborators

Recruiting

Trial Readiness and Endpoint Assessment in LGMD R1 (GRASP-01-003)

Limb Girdle Muscular Dystrophy | Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A | Limb Girdle Muscular Dystrophy Type R1 | LGMD2A

United States, Netherlands, United Kingdom
Radboud University Medical Center

Recruiting

A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy.

SELENON-related Myopathy | LAMA2-related Muscular Dystrophy

Netherlands
Radboud University Medical Center

Completed

The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2

MDC1A | SELENON-related Myopathy

Netherlands
Ixaka Ltd
Andalusian Network for Design and Translation of Advanced Therapies

Terminated

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

Cardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)

Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary

Clinical Trials on Limb Girdle Muscular Dystrophy R9 FKRP-related in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations